February 17, 2014
1 min read

pSivida reports net loss for second quarter

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

pSivida reported a net loss of $3.5 million, or $0.13 per share, for its second quarter, according to a press release.

This compares with a net loss of $2.6 million, or $0.11 per share, for the same quarter the previous year.

The loss was primarily attributed to costs associated with the company’s continuing involvement in a phase 3 clinical trial of Medidur for posterior uveitis.

Quarterly revenue was $592,000, an increase from $585,000 reported for the same period in 2012.